165 related articles for article (PubMed ID: 1120987)
1. Synthfsis of bis(aziridinyl)phosphinyl-N-hydroxyurethane derivatives as antineoplastic agents.
Hsiao YY; Bardos TJ; Wampler GL; Regelson W
J Med Chem; 1975 Feb; 18(2):195-8. PubMed ID: 1120987
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 5'-thymidinyl bis(1-aziridinyl)phosphinates as antineoplastic agents.
Hsiao LY; Bardos TJ
J Med Chem; 1981 Jul; 24(7):887-9. PubMed ID: 7277400
[TBL] [Abstract][Full Text] [Related]
3. Phosphorus-nitrogen compounds. 21. Murine oncolytic and antifertility effect of adamantylaziridine compounds.
Cates LA; Cramer MB; Williams L
J Med Chem; 1978 Jan; 21(1):143-6. PubMed ID: 619145
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of reactions of ring-substituted bis(1-aziridinyl)phosphinyl urethan antineoplastic agents.
Navada CK; Chmielewicz ZF; Bardos TJ
J Pharm Sci; 1970 Aug; 59(8):1079-83. PubMed ID: 5457322
[No Abstract] [Full Text] [Related]
5. Up-to-date improvements in inorganic ring systems as anticancer agents.
Labarre JF
Top Curr Chem; 1982; 102():1-87. PubMed ID: 6750846
[No Abstract] [Full Text] [Related]
6. Isomer-dependent cytostatic activity of bis(1-aziridinyl)cyclophosphazenes.
van der Huizen AA; Wilting T; van de Grampel JC; Lelieveld P; van der Meer-Kalverkamp A; Lamberts HB; Mulder NH
J Med Chem; 1986 Aug; 29(8):1341-5. PubMed ID: 3735303
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moieties.
Perlman ME; Dunn JA; Piscitelli TA; Earle J; Rose WC; Wampler GL; MacDiarmid JE; Bardos TJ
J Med Chem; 1991 Apr; 34(4):1400-7. PubMed ID: 2016716
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and properties of bis(2,2-dimethylaziridinyl)phosphinic amides: a series of new antineoplastic agents.
MacDiarmid JE; Rose WC; Biddle WC; Perlman ME; Breiner RG; Ambrus JL; Bardos TJ
J Med Chem; 1985 Nov; 28(11):1685-91. PubMed ID: 4067995
[TBL] [Abstract][Full Text] [Related]
9. Antitumour activity of some cyclophosphazenes.
Labarre JF; Faucher JP; Levy G; Sournies F; Cros S; François G
Eur J Cancer (1965); 1979 May; 15(5):637-43. PubMed ID: 510331
[No Abstract] [Full Text] [Related]
10. In the search for new anticancer drugs. VII. Platinum complexes of diaziridines and azetidine.
Sosnovsky G; Lukszo J
J Cancer Res Clin Oncol; 1984; 107(3):217-20. PubMed ID: 6547443
[TBL] [Abstract][Full Text] [Related]
11. Isolation, synthesis, and antitumor evaluation of spirohydantoin aziridine, a mutagenic metabolite of spirohydantoin mustard.
Struck RF; Kirk MC; Rice LS; Suling WJ
J Med Chem; 1986 Jul; 29(7):1319-21. PubMed ID: 3543361
[TBL] [Abstract][Full Text] [Related]
12. SYNTHESIS OF POTENTIAL DUAL ANTAGONISTS IV. EFFECT OF RING SUBSTITUENTS ON THE ALKYLATING AND HYDROLYTIC PROPERTIES OF BIS-(1-AZIRIDINYL)PHOSPHINYL CARBAMATES.
BARDOS TJ; CHMIELEWICZ ZF; NAVADA CK
J Pharm Sci; 1965 Mar; 54():399-403. PubMed ID: 14302149
[No Abstract] [Full Text] [Related]
13. Synthesis of 2,3-diaziridinyl-1,4-naphthoquinone sulfonate derivatives as potential antineoplastic agents.
Lin TS; Xu SP; Zhu LY; Cosby LA; Sartorelli AC
J Med Chem; 1989 Jul; 32(7):1467-71. PubMed ID: 2738880
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new nucleoside phosphoraziridines as potential site-directed antineoplastic agents.
Breiner RG; Rose WC; Dunn JA; MacDiarmid JE; Bardos TJ
J Med Chem; 1990 Sep; 33(9):2596-602. PubMed ID: 2391698
[TBL] [Abstract][Full Text] [Related]
15. In the search for new anticancer drugs. X. N,N; N',N'-bis(1,2-ethanediyl)-N''-(1-oxyl-2,2,6,6-tetramethyl- 4-piperidinylaminocarbonyl) phosphoric triamide--a new potential anticancer drug of high activity and low toxicity.
Sosnovsky G; Li SW
Life Sci; 1985 Apr; 36(15):1473-7. PubMed ID: 2580207
[TBL] [Abstract][Full Text] [Related]
16. Preparation and antitumor activity of 7-substituted 1,2-aziridinomitosenes.
Iyengar BS; Remers WA; Bradner WT
J Med Chem; 1986 Oct; 29(10):1864-8. PubMed ID: 3761307
[TBL] [Abstract][Full Text] [Related]
17. Heterocyclic quinones. 17. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8- quinazolinedione.
Giorgi-Renault S; Renault J; Gebel-Servolles P; Baron M; Paoletti C; Cros S; Bissery MC; Lavelle F; Atassi G
J Med Chem; 1991 Jan; 34(1):38-46. PubMed ID: 1992140
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of new urethans. p-Ethylsulfonyl- and p-dimethylsulfamoylcarbanilic acid esters.
Sharghi N; Lalezari I; Niloufari G; Ghabgharan F
J Med Chem; 1970 Nov; 13(6):1248. PubMed ID: 5479885
[No Abstract] [Full Text] [Related]
19. Synthesis of new bis(1-aziridinyl) phosphinate alkylating agents containing O-phenyl N-phenylcarbamate side chains.
Hsiao YY; Bardos TJ
J Med Chem; 1973 Apr; 16(4):391-4. PubMed ID: 4716182
[No Abstract] [Full Text] [Related]
20. Potential anti-tumour 2,5-bis (1-aziridinyl)-1,4-benzoquinones: relationship between cytotoxicity against DNA-repair deficient E. coli, inactivation of bacteriophage M13mp19, and in vitro and in vivo anti-tumour activity.
Lusthof KJ; Groothuis-Pielage IL; Decuyper J; de Mol NJ; Janssen LH; Verboom W; Reinhoudt DN
Anticancer Drug Des; 1988 Dec; 3(3):147-55. PubMed ID: 3061386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
